From Nasdaq: 2025-06-17 18:15:00

Astera Labs, Inc. (ALAB) saw a 2.51% decrease in stock price, closing at $92.91, underperforming the S&P 500, Dow, and Nasdaq. However, over the past month, ALAB shares rose by 5.23%, outperforming its sector and the S&P 500.

ALAB is expected to report an EPS of $0.33, a 153.85% increase from last year, with revenue projected at $172.71 million, a 124.74% jump. Full-year estimates predict earnings of $1.35 per share and revenue of $702.43 million, up 60.71% and 77.25%, respectively.

The Zacks Rank system rates ALAB as a #2 (Buy) stock, with positive estimate revisions suggesting optimism about the company’s outlook. The stock’s current Forward P/E ratio is 193.92, higher than the industry average of 45.44, and its PEG ratio is 4.48, compared to the industry’s 3.23.

Zacks Investment Research has identified Astera Labs, Inc. (ALAB) as one of the 7 Best Stocks for the Next 30 Days, with a history of outperforming the market. Investors are urged to pay attention to these elite stocks for potential early price pops. Visit Zacks.com for more stock-shifting metrics and recommendations.



Read more at Nasdaq: Here’s Why Astera Labs, Inc. (ALAB) Fell More Than Broader Market